AXIM
Price:
$0.005
Market Cap:
$1.70M
AXIM Biotechnologies, Inc. specializes in the creation and distribution of advanced diagnostic solutions for healthcare, focusing on critical areas such as SARS-CoV-2 (COVID-19), ocular health, and cancer treatment. The company is currently developing rapid diagnostic assays that quantify functional neutralizing antibodies, which are essential for preventing the SARS-CoV-2 virus from attaching to human cells. Additionally, it offers serological diagnostic tests designed to detect neutralizing antibodies, thereby assessing the body's adaptive immune response to the virus, and is developing tests to identify inflammation biomarkers for the effective management of COVID-19 patients. For eye hea...[Read more]
Industry
Biotechnology
IPO Date
2014-09-02
Stock Exchange
OTC
Ticker
AXIM
According to AXIM Biotechnologies, Inc.’s latest financial reports and current stock price. The company's current ROE is 4.91%. This represents a change of 92.03% compared to the average of 2.56% of the last 4 quarters.
The mean historical ROE of AXIM Biotechnologies, Inc. over the last ten years is 107.07%. The current 4.91% ROE has changed -95.42% with respect to the historical average. Over the past ten years (40 quarters), AXIM's ROE was at its highest in in the March 2020 quarter at 560.77%. The ROE was at its lowest in in the June 2021 quarter at -368.82%.
Average
107.07%
Median
102.71%
Minimum
-429.85%
Maximum
706.45%
Discovering the peaks and valleys of AXIM Biotechnologies, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 67.45%
Maximum Annual ROE = 706.45%
Minimum Annual Increase = -529.15%
Minimum Annual ROE = -429.85%
| Year | ROE | Change |
|---|---|---|
| 2025 | 9.18% | -72.78% |
| 2024 | 33.71% | -67.98% |
| 2023 | 105.26% | -14.73% |
| 2022 | 123.45% | -82.53% |
| 2021 | 706.45% | -264.35% |
| 2020 | -429.85% | -529.15% |
| 2019 | 100.16% | -9.81% |
| 2018 | 111.06% | 67.45% |
| 2017 | 66.33% | -72.93% |
| 2016 | 244.98% | -58.85% |
The current ROE of AXIM Biotechnologies, Inc. (AXIM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
49.38%
5-year avg
195.61%
10-year avg
107.07%
AXIM Biotechnologies, Inc.’s ROE is greater than Acrux Limited (-211.88%), greater than HAVN Life Sciences Inc. (-274.69%), greater than ProtoKinetix, Incorporated (-116.26%), less than Zelira Therapeutics Limited (56.41%), less than Sigyn Therapeutics, Inc. (62.07%), greater than ReNeuron Group plc (-72.37%), less than RepliCel Life Sciences Inc. (1.86%), greater than Polarean Imaging plc (-73.99%), less than Radient Technologies Inc. (0%), less than LiveWire Ergogenics, Inc. (404.32%),
| Company | ROE | Market cap |
|---|---|---|
| -211.88% | $6.78M | |
| -274.69% | $2.56K | |
| -116.26% | $2.04M | |
| 56.41% | $4.16M | |
| 62.07% | $62.61K | |
| -72.37% | $62.89K | |
| 1.86% | $7.00K | |
| -73.99% | $7.97M | |
| 0% | $5.40K | |
| 404.32% | $1.16M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AXIM Biotechnologies, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AXIM Biotechnologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is AXIM Biotechnologies, Inc.'s ROE?
How is the ROE calculated for AXIM Biotechnologies, Inc. (AXIM)?
What is the highest ROE for AXIM Biotechnologies, Inc. (AXIM)?
What is the 3-year average ROE for AXIM Biotechnologies, Inc. (AXIM)?
What is the 5-year average ROE for AXIM Biotechnologies, Inc. (AXIM)?
How does the current ROE for AXIM Biotechnologies, Inc. (AXIM) compare to its historical average?